Literature DB >> 23719195

Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin.

Gary E Borodic1, Paul Caruso, Martin Acquadro, Sarah Chick.   

Abstract

Parry-Romberg syndrome is a rare condition characterized by progressive, hemifacial atrophy, hair loss, enophthalmos, retinal vasculopathy occasionally associated with hemicranial pain syndrome (secondary trigeminal neuralgia). The cause of the condition is unknown; however, substantial evidence suggests that vasculopathy plays a significant role in the genesis of the neurologic damage and facial lipodystrophy. Herein describes a case of Parry-Romberg syndrome treated with repetitive botulinum type A toxin injections, with almost complete resolution of severe chronic pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23719195     DOI: 10.1097/IOP.0b013e31828de9c0

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

Review 1.  Progressive hemifacial atrophy: a review.

Authors:  Stanislav N Tolkachjov; Nirav G Patel; Megha M Tollefson
Journal:  Orphanet J Rare Dis       Date:  2015-04-01       Impact factor: 4.123

2.  Acral Necrosis in a COVID-19-Infected Man Treated with Botulinum Toxin Type A.

Authors:  Mette Soelberg Schjødt; Rikke Bech; Anne Braae Olesen
Journal:  Case Rep Dermatol       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.